{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:35:18Z","timestamp":1761100518174,"version":"3.30.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,11,1]]},"DOI":"10.1038\/sj.bmt.1702689","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:42:43Z","timestamp":1031154163000},"page":"1037-1043","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy"],"prefix":"10.1038","volume":"26","author":[{"given":"EA","family":"Copelan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SL","family":"Penza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KS","family":"Theil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PJ","family":"Elder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TP","family":"Bechtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MB","family":"Tighe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SA","family":"Ezzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MD","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PS","family":"Belt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DC","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BR","family":"Avalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,11,20]]},"reference":[{"key":"BF1702689_CR1","unstructured":"Goldman JM . Chronic myeloid leukemia: new strategies for cure Education Program American Society of Hematology 1997 pp 1\u20137"},{"key":"BF1702689_CR2","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"CL Sawyers","year":"1999","unstructured":"Sawyers CL . Chronic myeloid leukemia New Engl J Med 1999 340: 1330\u20131340","journal-title":"New Engl J Med"},{"key":"BF1702689_CR3","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1200\/JCO.1998.16.9.2897","volume":"16","author":"SJ Lee","year":"1998","unstructured":"Lee SJ, Anasetti C, Horowitz MH, Antin JH . Initial therapy for chronic myelogenous leukemia: playing the odds J Clin Oncol 1998 16: 2897\u20132903","journal-title":"J Clin Oncol"},{"key":"BF1702689_CR4","first-page":"1810","volume":"91","author":"RP Gale","year":"1998","unstructured":"Gale RP, Hehlman R, Zhang M-J et al . for the German CML Study Group Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia Blood 1998 91: 1810\u20131819","journal-title":"Blood"},{"key":"BF1702689_CR5","first-page":"S5","volume":"17","author":"MM Horowitz","year":"1996","unstructured":"Horowitz MM, Rowlings PA, Passweg JR . Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry Bone Marrow Transplant 1996 17: (Suppl. 1) S5\u2013S6","journal-title":"Bone Marrow Transplant"},{"key":"BF1702689_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/sj.bmt.1700933","volume":"20","author":"F van Rhee","year":"1997","unstructured":"van Rhee F, Szydlo RM, Hermans J et al . for the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 1997 20: 553\u2013560","journal-title":"Bone Marrow Transplant"},{"key":"BF1702689_CR7","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1182\/blood.V84.12.4368.bloodjournal84124368","volume":"84","author":"RA Clift","year":"1994","unstructured":"Clift RA, Buckner CD, Thomas ED et al. Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia Blood 1994 84: 4368\u20134373","journal-title":"Blood"},{"key":"BF1702689_CR8","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood.V82.7.2235.2235","volume":"82","author":"JM Goldman","year":"1993","unstructured":"Goldman JM, Szydlo R, Horowitz MM et al. Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase Blood 1993 82: 2235\u20132238","journal-title":"Blood"},{"key":"BF1702689_CR9","first-page":"S203","volume":"15","author":"CD Buckner","year":"1995","unstructured":"Buckner CD, Clift RA . Timing of allogeneic marrow transplants for patients with chronic myeloid leukemia Bone Marrow Transplant 1995 15: (Suppl. 1) S203\u2013S206","journal-title":"Bone Marrow Transplant"},{"key":"BF1702689_CR10","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1056\/NEJM199804023381405","volume":"338","author":"JA Hansen","year":"1998","unstructured":"Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplantation from unrelated donors for patients with chronic myeloid leukemia New Engl J Med 1998 338: 962\u2013968","journal-title":"New Engl J Med"},{"key":"BF1702689_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.7326\/0003-4819-131-3-199908030-00008","volume":"131","author":"S Faderl","year":"1999","unstructured":"Faderl S, Talpaz M, Estrov Z, Kantarjian HM . Chronic myelogenous leukemia: biology and therapy Ann Intern Med 1999 131: 207\u2013219","journal-title":"Ann Intern Med"},{"key":"BF1702689_CR12","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","volume":"309","author":"GW Santos","year":"1983","unstructured":"Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide New Engl J Med 1983 309: 1347\u20131353","journal-title":"New Engl J Med"},{"key":"BF1702689_CR13","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V70.5.1382.1382","volume":"70","author":"PJ Tutschka","year":"1987","unstructured":"Tutschka PJ, Copelan EA, Klein J . Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen Blood 1987 70: 1382\u20131388","journal-title":"Blood"},{"key":"BF1702689_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-2141.1989.tb06307.x","volume":"71","author":"EA Copelan","year":"1989","unstructured":"Copelan EA, Grever MR, Kapoor N, Tutschka PJ . Marrow transplantation following busulfan and cyclophosphamide for CML in accelerated or blastic phase Br J Haematol 1989 71: 487\u2013491","journal-title":"Br J Haematol"},{"key":"BF1702689_CR15","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1182\/blood.V80.5.1352.1352","volume":"80","author":"JC Biggs","year":"1992","unstructured":"Biggs JC, Szer J, Crilley P et al. Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy 2 Blood 1992 80: 1352\u20131357","journal-title":"Blood"},{"key":"BF1702689_CR16","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood.V84.6.2036.2036","volume":"84","author":"RA Clift","year":"1994","unstructured":"Clift RA, Buckner CD, Thomas ED et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide Blood 1994 84: 2036\u20132043","journal-title":"Blood"},{"key":"BF1702689_CR17","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.V85.8.2263.bloodjournal8582263","volume":"85","author":"A Devergie","year":"1995","unstructured":"Devergie A, Blaise D, Attal M et al . for The French Society of Bone Marrow Graft (SFGM) Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan\u2013cytoxan versus cytoxan\u2013total body irradiation as preparative regimen: a report from The French Society of Bone Marrow Graft (SFGM) Blood 1995 85: 2263\u20132268","journal-title":"Blood"},{"key":"BF1702689_CR18","first-page":"479","volume":"17","author":"JL Klein","year":"1996","unstructured":"Klein JL, Avalos BR, Belt P et al. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy Bone Marrow Transplant 1996 17: 479\u2013483","journal-title":"Bone Marrow Transplant"},{"key":"BF1702689_CR19","first-page":"685","volume":"17","author":"F Sahebi","year":"1996","unstructured":"Sahebi F, Copelan E, Crilley P et al. Unrelated allogeneic bone marrow transplantation using high dose busulfan and cyclosphosphamide (Bu-Cy) for the preparative regimen Bone Marrow Transplant 1996 17: 685\u2013689","journal-title":"Bone Marrow Transplant"},{"key":"BF1702689_CR20","first-page":"583","volume":"13","author":"J Mehta","year":"1994","unstructured":"Mehta J, Powles RL, Mitchell P et al. Graft failure after bone marrow transplantation from unrelated donors using busulphan and cyclophosphamide for conditioning Bone Marrow Transplant 1994 13: 583\u2013587","journal-title":"Bone Marrow Transplant"},{"key":"BF1702689_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients Ann Intern Med 1993 118: 255\u2013267","journal-title":"Ann Intern Med"},{"key":"BF1702689_CR22","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","volume":"93","author":"O Ringden","year":"1999","unstructured":"Ringden O, Remberger M, Ruutu T et al. for the Nordic Bone Marrow Transplantation Group Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia Blood 1999 93: 2196\u20132201","journal-title":"Blood"},{"key":"BF1702689_CR23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1182\/blood.V82.3.691.691","volume":"82","author":"HM Kantarjian","year":"1993","unstructured":"Kantarjian HM, Deisseroth A, Kurzrock R et al. Chronic myelogenous leukemia: a concise update Blood 1993 82: 691\u2013703","journal-title":"Blood"},{"key":"BF1702689_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Gluckberg","year":"1974","unstructured":"Gluckberg H, Storb R, Fefer A et al. Clinical manifestation of graft-versus host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295\u2013304","journal-title":"Transplantation"},{"key":"BF1702689_CR25","first-page":"545","volume":"91","author":"HM Shulman","year":"1978","unstructured":"Shulman HM, Sale GE, Lerner KG et al. Chronic cutaneous graft-versus-host disease in man Am J Pathol 1978 91: 545\u2013570","journal-title":"Am J Pathol"},{"key":"BF1702689_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.7326\/0003-4819-111-5-368","volume":"111","author":"JG Clark","year":"1989","unstructured":"Clark JG, Crawford SW, Madtes DK, Sullivan KM . Obstructive lung disease after allogeneic marrow transplantation Ann Intern Med 1989 111: 368\u2013376","journal-title":"Ann Intern Med"},{"key":"BF1702689_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF1702689_CR28","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel N . Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 1966 50: 163\u2013170","journal-title":"Cancer Chemother Rep"},{"key":"BF1702689_CR29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR . Regression models and life tables J Roy Stat Soc 1972 34: 187\u2013220","journal-title":"J Roy Stat Soc"},{"key":"BF1702689_CR30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/blood.V79.1.276.276","volume":"79","author":"MS Roth","year":"1992","unstructured":"Roth MS, Antin JH, Ash R et al. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplantation for chronic myelogenous leukemia Blood 1992 79: 276\u2013282","journal-title":"Blood"},{"key":"BF1702689_CR31","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood.V85.9.2632.bloodjournal8592632","volume":"85","author":"JP Radich","year":"1995","unstructured":"Radich JP, Gehly G, Gooley T et al. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients Blood 1995 85: 2632\u20132638","journal-title":"Blood"},{"key":"BF1702689_CR32","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V94.2.384","volume":"94","author":"AH Elmaagacli","year":"1999","unstructured":"Elmaagacli AH, Beelen DW, Opalka B et al. The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow Blood 1999 94: 384\u2013389","journal-title":"Blood"},{"key":"BF1702689_CR33","first-page":"509","volume":"12","author":"A Gratwohl","year":"1993","unstructured":"Gratwohl A, Hermans J, Niederwieser D . Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation Bone Marrow Transplant 1993 12: 509\u2013516","journal-title":"Bone Marrow Transplant"},{"key":"BF1702689_CR34","first-page":"405","volume":"22","author":"FR Applebaum","year":"1995","unstructured":"Applebaum FR, Clift R, Radich J et al. Bone marrow transplantation for chronic myelogenous leukemia Semin Oncol 1995 22: 405\u2013411","journal-title":"Semin Oncol"},{"key":"BF1702689_CR35","first-page":"51","volume":"17","author":"RA Clift","year":"1996","unstructured":"Clift RA, Storb R . Marrow transplantation for CML: the Seattle experience Bone Marrow Transplant 1996 17: (Suppl. 3) 51\u201353","journal-title":"Bone Marrow Transplant"},{"key":"BF1702689_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0002-9343(99)80189-2","volume":"99","author":"M Wetzler","year":"1995","unstructured":"Wetzler M, Kantarjian H, Kurzrock R, Talpaz M . Interferon-\u03b1 therapy for chronic myelogenous leukemia Am J Med 1995 99: 402\u2013411","journal-title":"Am J Med"},{"key":"BF1702689_CR37","first-page":"495a (Abstr.)","volume":"92","author":"A Hochhaus","year":"1998","unstructured":"Hochhaus A, Hehlmann R, Kolb HJ et al. and the German CML Study Group Mannheim, Germany. The outcome of allogeneic bone marrow transplantation is strongly influenced by early discontinuation of interferon-alpha pretreatment in patients with chronic myeloid leukemia Blood 1998 92: 495a (Abstr.)","journal-title":"Blood"},{"key":"BF1702689_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V93.12.4436","volume":"93","author":"JP Gibbs","year":"1999","unstructured":"Gibbs JP, Gooley T, Corneau B et al. The impact of obesity and disease on busulfan oral clearance in adults Blood 1999 93: 1\u20136","journal-title":"Blood"},{"key":"BF1702689_CR39","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1200\/JCO.1996.14.5.1484","volume":"14","author":"JT Slattery","year":"1996","unstructured":"Slattery JT, Kalhorn TF, McDonald GB et al. Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients J Clin Oncol 1996 14: 1484\u20131494","journal-title":"J Clin Oncol"},{"key":"BF1702689_CR40","first-page":"pp 1628","volume-title":"Hematology. Basic Principles and Practice, 3rd edn","author":"EA Copelan","year":"1999","unstructured":"Copelan EA, Penza SL . Preparative regimens for stem cell transplantation. In: Hoffman R, Benz EJ Jr, Shattil SJ et al (eds) Hematology. Basic Principles and Practice, 3rd edn Churchill Livingstone: New York 1999 pp 1628\u20131642"},{"key":"BF1702689_CR41","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.V76.5.1037.1037","volume":"76","author":"R Storb","year":"1990","unstructured":"Storb R, Pepe M, Anasetti C et al. What role for prednisone in prevention of acute graft-vs-host disease in patients undergoing marrow transplants? Blood 1990 76: 1037\u20131045","journal-title":"Blood"},{"key":"BF1702689_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1200\/JCO.1992.10.2.237","volume":"10","author":"EA Copelan","year":"1992","unstructured":"Copelan EA, Biggs JC, Avalos BR et al. Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia J Clin Oncol 1992 10: 237\u2013242","journal-title":"J Clin Oncol"},{"key":"BF1702689_CR43","first-page":"31","volume":"16","author":"JT Slattery","year":"1995","unstructured":"Slattery JT, Sanders JE, Buckner CD et al. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics Bone Marrow Transplant 1995 16: 31\u201342","journal-title":"Bone Marrow Transplant"},{"key":"BF1702689_CR44","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1182\/blood.V89.8.3055","volume":"89","author":"JT Slattery","year":"1997","unstructured":"Slattery JT, Clift RA, Buckner CD et al. Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation Blood 1997 89: 3055\u20133060","journal-title":"Blood"},{"key":"BF1702689_CR45","first-page":"18","volume":"20","author":"LB Grochow","year":"1993","unstructured":"Grochow LB . The role of therapeutic monitoring in bone marrow transplantation induction regimens Semin Oncol 1993 20: (Suppl. 4) 18\u201325","journal-title":"Semin Oncol"},{"key":"BF1702689_CR46","unstructured":"Andersson BS, Fernandez H, Cagnoni P et al. IV busulfan, cyclophosphamide (BuCy) and hemopoietic stem cells for non-Hodgkin's lymphomas (NHL) Proceedings of the American Society for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry\/Autologous Blood and Marrow Transplant Registry Tandem BMT Meetings, Keystone Resort, CO, February 28\u2013March 6 1999 2: p 3 (Abstr.)"},{"key":"BF1702689_CR47","unstructured":"Vaughan WP, Cagnoni P, Fernandez H et al. Pharmacokinetics of intravenous busulfan in hematopoietic stem cell transplantation (HSCT) Proceedings of the American Society for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry\/Autologous Blood and Marrow Transplant Registry Tandem BMT Meetings, Keystone Resort, CO, February 28\u2013March 6 1999 78: p 22 (Abstr.)"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702689","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702689.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702689.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T11:20:03Z","timestamp":1733570403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,1]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2000,11,1]]}},"alternative-id":["BF1702689"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702689","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2000,11,1]]},"assertion":[{"value":"2 May 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}